Back to Market Feed

ZORYVE 0.15% CREAM

roflumilast
$15.3893per GM
High Outlier

Strength

1.5 mg/g

NDC

80610011560

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Last Updated

1/1/2026

Active Ingredients

ROFLUMILAST

Approval Type

New Drug (NDA)

FDA Application

NDA215985

On Market Since

7/9/2024

Pharmacological Classes

Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.1%

1Y

+4.3%

3Y

N/A

5Y

N/A

All

+9.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

EUCRISA 2% OINTMENT
Brand
55724021111•Pfizer Inc.
$10.6810
per GM
EUCRISA 2% OINTMENT
Brand
55724021121•Pfizer Inc.
$12.6464
per GM
OTEZLA 20 MG TABLET
Brand
55513049760•Amgen Inc.
$89.9522
per EA
OTEZLA 30 MG TABLET
Brand
55513013760•Amgen Inc.
$90.6993
per EA